Assessment the therapeutic potential and safety profile of traditional antiobesity herbal drugs in Saudi Arabia

Pharmacology, Toxicology and Pharmaceutical Science

1. Herbaceous Agent 100%
2. Diseases 91%
3. Side Effect 41%
4. Salicylate Sodium 33%
5. Lipoprotein 25%
6. Antiobesity Drugs 25%
7. Pharmacotherapy 16%
8. Flavonoid 16%
9. Alanine Aminotransferase 16%
10. Medicinal Plant 16%
11. Leptin 16%
12. Natural Product 16%
13. Chronic Disease 16%
14. Adverse Event 16%
15. Kidney Disease 8%
16. Clinical Trial 8%
17. Pharmacodynamics 8%
18. Creatinine 8%
19. Nonalcoholic Fatty Liver 8%
20. Pathophysiology 8%
21. Respiratory Tract Disease 8%
22. Ureaplasma 8%
23. Calorimetry 8%
24. Aspartate Aminotransferase 8%
25. Diet Induced Obesity 8%
26. Experimental Animal 8%
27. Triacylglycerol 8%
28. Structure Activity Relationship 8%
29. Bioavailability 8%
30. Prevalence 8%
31. Dietary Supplement 8%
32. Morbid Obesity 8%
33. Lung Cancer 8%
34. Acute Disease 8%
35. Carvedilol 8%
36. Chronic Toxicity Study 8%
37. Ischemic Heart Disease 8%
38. Genetic Disorder 8%
39. Prematurity 8%
40. Cardiovascular Disease 8%
41. Rat 8%
42. Glucose 8%
43. Nitrogen 8%